Clinical trial
Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
NCT00061360 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00061360 |
|---|---|
| Title | Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia |
| Official title | A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects With Severe Aplastic Anemia |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Severe Aplastic Anemia |
| Intervention type | Drug |
| Interventions | ATG+Rapamune+cyclosporine, ATG+cyclosporine |
| Enrollment | 77 |
| Start date | Jun 26, 2003 |
| Primary completion | Feb 15, 2006 |
| Completion | Sep 8, 2015 |
| First posted | May 26, 2003 |
| Last update posted | Jun 30, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: